Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
News Feed

FCK Foundation licenses StrikeForce’s Mobile & Authentication Technologies to Protect Wallet Transactions

March 9, 2022 The Wall Street Analyzer Comments Off on FCK Foundation licenses StrikeForce’s Mobile & Authentication Technologies to Protect Wallet Transactions

StrikeForce to Receive 50% of Net Proceeds on All Transaction Fees EDISON, N.J., March 08, 2022 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTCQB: SFOR), a cyber security company that provides next-gen cyber, privacy & data protection solutions […]

No Picture
News Feed

Citius Pharmaceuticals, Inc. to Present at Upcoming March 2022 Conferences

March 4, 2022 The Wall Street Analyzer Comments Off on Citius Pharmaceuticals, Inc. to Present at Upcoming March 2022 Conferences

34th Annual ROTH Conference March 13-15, 2022 Maxim’s 2022 Virtual Growth Conference March 28-30, 2022 CRANFORD, N.J., March 3, 2022 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to […]

News Feed

SafeVchat™ Sees Demand Surge from Healthcare Providers for Secure Video Conferencing Solutions as Russian Threat Intensifies

March 2, 2022 The Wall Street Analyzer Comments Off on SafeVchat™ Sees Demand Surge from Healthcare Providers for Secure Video Conferencing Solutions as Russian Threat Intensifies

EDISON, N.J., March 01, 2022 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTCQB: SFOR), a Cyber Security company that provides next-gen secure video conferencing, today announced that on the heels of the Russian invasion of Ukraine it has […]

News Feed

IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal Q1 2022 Results

February 15, 2022 The Wall Street Analyzer Comments Off on IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal Q1 2022 Results

Placentia, California–(Newsfile Corp. – February 14, 2022) – InVitro International (OTC Pink: IVRO), a leading provider of non-animal testing methods, today announced revenues of $183,561 and net income of $56,940 for its first fiscal quarter […]